Connect Sign In
LabMind podcasts
Benjamin Bradley, MD, PhD, medical director of the ARUP Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, participated in a media briefing about the measles virus with the College of American Pathologists. |
March 13, 2025 |
ARUP Medical Director: Laboratory Testing and Vaccination Are Essential To Stop Measles Outbreaks Recent measles outbreaks are concerning. To assist in detecting measles virus and determining immunity, ARUP currently provides testing for IgM and IgG antibodies. |
Research highlights will include applications of RNA sequencing, long-read whole genome sequencing, and cytogenetics in the identification of rare and undiagnosed diseases, confirmation of novel variants, the curation of standardized reports for pharmacogenetics testing, and more. |
March 12, 2025 |
Solving Undiagnosed Cases and Featuring Other Research Highlights at the Upcoming ACMG 2025 Meeting Join ARUP at the 2025 ACMG annual meeting to explore the latest in laboratory genetics research, including how traditional and innovative test strategies can evaluate rare and undiagnosed cases. |
|
March 11, 2025 | Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology. |
The robotic arm removes the wet-mount specimen slide in preparation for scanning. Once scanned, the image will be screened via artificial intelligence (AI) for evidence of ova and parasites. |
March 6, 2025 |
ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection and Diagnosis ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process. |
Tracy I. George, MD, ARUP Laboratories’ chief scientific officer and president of the Innovation Business Unit, detailed ARUP’s commitment to cutting-edge diagnostic research during a Rare Disease Day event hosted at Recursion on February 27. The podium featured a zebra, the mascot of people with rare diseases. |
March 3, 2025 |
ARUP Highlights Its Commitment to Vital Diagnostic Research on Rare Disease Day Because an estimated one in 10 Americans lives with a rare disease, ARUP is committed to investing in the diagnostic research and innovation that will help bring them answers. |
ARUP CEO Andy Theurer, Chief Scientific Officer Tracy George, and BioHive leaders watch a video featuring George after ARUP received the Best of BioHive Community Impact Award on Thursday. |
February 21, 2025 |
ARUP Honored With Inaugural Best of BioHive Award for Community Impact The award recognizes the work ARUP does to educate, advocate, and innovate while continuously pushing to improve patient care. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat